Biotech

All Articles

Addex sell climbs after Indivior offers up to $300M for compound

.Indivior is actually getting a small particle allosteric modulator tailored to manage drug make use...

Molecular Allies changes AML trial over 'suboptimal exposure'

.Molecular Companions has actually recognized "suboptimal exposure" to its own tetra-specific T-cell...

Despite blended market, a venture capital rebirth might be being available in Europe: PitchBook

.While the biotech assets performance in Europe has actually decreased relatively following a COVID-...

8 months after a $213M fundraise, gene editor Volume helps make decreases

.After raising $213 million in 2023-- among the year's biggest personal biotech rounds-- Tome Biosci...

BioMarin develops officer team along with biotech veterinarians-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial management hirings, firings an...

Biopharma Q2 VC struck highest level because '22, while M&ampA decreased

.Venture capital backing right into biopharma cheered $9.2 billion across 215 handle the 2nd quarter...

Bicara, Zenas find IPOs to push late-phase assets toward market

.Bicara Therapies and Zenas Biopharma have delivered fresh motivation to the IPO market along with f...

Genentech to finalize cancer immunology investigation team

.Genentech is going to shut its cancer cells immunology investigation department, and device mind an...

Kezar falls solid tumor however to verify its own really worth in stage 1 test

.Kezar Life Sciences is actually falling its unpromising period 1 solid cyst medicine as the biotech...

Acelyrin drops izokibep, drops 3rd of workers

.Despite izokibep sustaining its own newfound winning touch in the clinic, Acelyrin is no longer pay...